| 000 | 01792 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515215232.0 | ||
| 264 | 0 | _c20110217 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2010.03644.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeissner, M | |
| 245 | 0 | 0 |
_aHuman leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cNov 2010 |
||
| 300 |
_a1326-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntigen Presentation _ximmunology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDermatofibrosarcoma _ximmunology |
| 650 | 0 | 4 |
_aDown-Regulation _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistiocytoma, Malignant Fibrous _ximmunology |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xmetabolism |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aTumor Escape _ximmunology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKönig, V | |
| 700 | 1 | _aHrgovic, I | |
| 700 | 1 | _aValesky, E | |
| 700 | 1 | _aKaufmann, R | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 24 _gno. 11 _gp. 1326-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2010.03644.x _zAvailable from publisher's website |
| 999 |
_c19699238 _d19699238 |
||